Plandai Biotechnology Inc (PLPL)
0.0004
0.00 (0.00%)
USD |
OTCM |
Apr 25, 15:59
Plandai Biotechnology Cash from Financing (TTM): 1.323M for March 31, 2017
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2017 | 1.323M |
December 31, 2016 | 1.567M |
September 30, 2016 | 1.051M |
June 30, 2016 | 1.193M |
March 31, 2016 | 2.624M |
December 31, 2015 | 1.906M |
September 30, 2015 | 2.386M |
June 30, 2015 | 4.034M |
March 31, 2015 | 1.650M |
December 31, 2014 | 3.895M |
September 30, 2014 | 3.502M |
June 30, 2014 | 2.446M |
March 31, 2014 | 3.696M |
December 31, 2013 | 2.051M |
September 30, 2013 | 3.613M |
June 30, 2013 | 4.327M |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 |
Date | Value |
---|---|
December 31, 2011 | |
September 30, 2011 | -0.2612M |
June 30, 2011 | -0.2719M |
March 31, 2011 | -0.3239M |
December 31, 2010 | 0.3584M |
September 30, 2010 | 0.3851M |
June 30, 2010 | 0.3046M |
March 31, 2010 | 0.5159M |
December 31, 2009 | -0.0775M |
September 30, 2009 | -0.1318M |
June 30, 2009 | -0.1939M |
March 31, 2009 | -0.3548M |
December 31, 2008 | -0.1857M |
September 30, 2008 | -0.463M |
June 30, 2008 | -0.5659M |
March 31, 2008 | -0.8108M |
December 31, 2007 | 0.9247M |
September 30, 2007 | 1.504M |
June 30, 2007 | 2.237M |
March 31, 2007 | 2.539M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
Quantum Fintech Acquisition Corp (DELISTED) | -150.55M |
BlueRiver Acquisition Corp | -272.69M |
Jaws Mustang Acquisition Corp | -1.031B |
Bite Acquisition Corp | 0.7509M |
Williams Rowland Acquisition Corp (DELISTED) | -- |